Evaluation of Rehabilitation Results in the Single-sided Deafness With Cochlear Implantation

Sponsor
Chinese PLA General Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05435612
Collaborator
(none)
30
2
48

Study Details

Study Description

Brief Summary

Single-sided deafness (SSD) refers to severe to profound sensorineural hearing loss on one side (average pure-tone hearing threshold≥70 dB HL at 0.5, 1, 2, and 4kHz) while the opposite side maintains normal hearing or mild hearing loss (30 dB HL). Asymmetrical hearing loss (AHL) refers to severe to profound sensorineural hearing loss in the bad ear (average pure-tone hearing threshold≥70 dB HL at 0.5, 1, 2, and 4kHz) and mild to moderate hearing loss in the contralateral ear. Moderate hearing loss (30≤mean pure-tone hearing threshold≤55dBHL). It is generally acknowledged that SSD is a particular clinical manifestation of AHL. The number of people who have hearing loss accounts for 5.3% of the total population, with children for 9%. According to the Second National Sampling Survey on Disabled Persons, China has 27.8 million people with hearing disabilities. The incidence of SSD adults in the United States is 7.2%, with 60,000 new cases per year, compared with 7,500 new patients with SSD annually in the UK. The incidence of SSD in neonates is 0.04%-0.34%, and it ranges from 0.1% to 0.5% in children and adolescents. The etiology of congenital SSD is primarily unknown, which is related to genes. Among the causes of acquired SSD, sudden deafness is the most common. Other causes include head trauma, Meniere's disease, labyrinthitis, unilateral acoustic neuroma, middle ear surgery, ototoxic drug exposure, Virus infection, noise-induced deafness, senile deafness, etc.

SSD and AHL impede intellectual development and speech development in children and adolescents, which is associated with the side of hearing loss. For example, children with right-sided hearing loss have relatively poor language learning, logical thinking, and divergent thinking. In contrast, children with left-sided hearing loss have weaker analytical, comprehensive and visual memory abilities and relatively poor spatial imagination and visual-motor coordination. In addition, the lack of long-term monaural listening and sound source localization makes SSD children require excessive concentration, which is prone to fatigue and behavioral problems, and their academic performance is lower than that of normal children.

Condition or Disease Intervention/Treatment Phase
  • Device: cochlear implant
N/A

Detailed Description

Current options for hearing interventions for patients with SSD are air conduction hearing aids, bone conduction hearing aids and cochlear implants. Attributed to the United States Food and Drug Administration (FDA) approval of one manufacturer's CI for patients aged five years and older with SSD in 2019, CI has been considered by the growing population. However, few studies on CI in patients with SSD, especially in China. Therefore, the study aims to evaluate the efficacy of CI in SSD patients.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of Rehabilitation Results in the Single-sided Deafness/Asymmetrical Hearing Loss With Cochlear Implantation
Anticipated Study Start Date :
Jul 1, 2022
Anticipated Primary Completion Date :
Jul 1, 2025
Anticipated Study Completion Date :
Jul 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: single-sided deafness group(SSD Group)

The single-sided group(SSD group)consists of 20 SSD patients voluntarily enrolled in the study and plan to undergo cochlear implantation.

Device: cochlear implant
Patients enrolled in the study undergo the cochlear implant surgery.

Experimental: asymmetric hearing loss group(AHL Group)

The asymmetric hearing loss group(AHL group)consists of 10 AHL patients voluntarily enrolled in the study and plan to undergo cochlear implantation.

Device: cochlear implant
Patients enrolled in the study undergo the cochlear implant surgery.

Outcome Measures

Primary Outcome Measures

  1. speech recognition [The tests are conducted before the cochlear implantation.]

    Both speech recognition score and speech recognition threshold are conducted to assess the auditory sensitivity and articulation of the spoken language. That is to evaluate the subjects' ability to recognize and understand speech in actual communication.

  2. speech recognition [The tests are conducted 1 months after CI activation.]

    Both speech recognition score and speech recognition threshold are conducted to assess the auditory sensitivity and articulation of the spoken language. That is to evaluate the subjects' ability to recognize and understand speech in actual communication.

  3. speech recognition [The tests are conducted 3 months after CI activation.]

    Both speech recognition score and speech recognition threshold are conducted to assess the auditory sensitivity and articulation of the spoken language. That is to evaluate the subjects' ability to recognize and understand speech in actual communication.

  4. speech recognition [The tests are conducted 6 months after CI activation.]

    Both speech recognition score and speech recognition threshold are conducted to assess the auditory sensitivity and articulation of the spoken language. That is to evaluate the subjects' ability to recognize and understand speech in actual communication.

  5. speech recognition [The tests are conducted 12 months after CI activation.]

    Both speech recognition score and speech recognition threshold are conducted to assess the auditory sensitivity and articulation of the spoken language. That is to evaluate the subjects' ability to recognize and understand speech in actual communication.

  6. sound localization [The test is conducted before the cochlear implantation.]

    180° (horizonal) sound localization test is conducted to assess the sound source localization ability (pre-/post-operation).

  7. sound localization [The test is conducted 1 months after CI activation.]

    180° (horizonal) sound localization test is conducted to assess the sound source localization ability (pre-/post-operation).

  8. sound localization [The test is conducted 3 months after CI activation.]

    180° (horizonal) sound localization test is conducted to assess the sound source localization ability (pre-/post-operation).

  9. sound localization [The test is conducted 6 months after CI activation.]

    180° (horizonal) sound localization test is conducted to assess the sound source localization ability (pre-/post-operation).

  10. sound localization [The test is conducted 12 months after CI activation.]

    180° (horizonal) sound localization test is conducted to assess the sound source localization ability (pre-/post-operation).

  11. Objective electroencephalography-based assessment(EEG) [The test is conducted before the cochlear implantation.]

    EEG is a non-invasive objective assessment technique that records brain activity along with specific neural pathways. we utilize cortical auditory evoked potential (CAEP) and event-related potentials(ERP) to obtain time-domain analysis.

  12. Objective electroencephalography-based assessment(EEG) [The test is conducted 1 months after CI activation.]

    EEG is a non-invasive objective assessment technique that records brain activity along with specific neural pathways. we utilize cortical auditory evoked potential (CAEP) and event-related potentials(ERP) to obtain time-domain analysis.

  13. Objective electroencephalography-based assessment(EEG) [The test is conducted 3 months after CI activation.]

    EEG is a non-invasive objective assessment technique that records brain activity along with specific neural pathways. we utilize cortical auditory evoked potential (CAEP) and event-related potentials(ERP) to obtain time-domain analysis.

  14. Objective electroencephalography-based assessment(EEG) [The test is conducted 6 months after CI activation.]

    EEG is a non-invasive objective assessment technique that records brain activity along with specific neural pathways. we utilize cortical auditory evoked potential (CAEP) and event-related potentials(ERP) to obtain time-domain analysis.

  15. Objective electroencephalography-based assessment(EEG) [The test is conducted 12 months after CI activation.]

    EEG is a non-invasive objective assessment technique that records brain activity along with specific neural pathways. we utilize cortical auditory evoked potential (CAEP) and event-related potentials(ERP) to obtain time-domain analysis.

Secondary Outcome Measures

  1. THI (Tinnitus Handicap Inventory) [The test is conducted before the cochlear implantation.]

    The tinnitus-related questionnaire has a comprehensive understanding of tinnitus from three aspects(functional scale, emotional scale and catastrophic scale).

  2. THI (Tinnitus Handicap Inventory) [The test is conducted 1 months after CI activation.]

    The tinnitus-related questionnaire has a comprehensive understanding of tinnitus from three aspects(functional scale, emotional scale and catastrophic scale).

  3. THI (Tinnitus Handicap Inventory) [The test is conducted 3 months after CI activation.]

    The tinnitus-related questionnaire has a comprehensive understanding of tinnitus from three aspects(functional scale, emotional scale and catastrophic scale).

  4. THI (Tinnitus Handicap Inventory) [The test is conducted 6 months after CI activation.]

    The tinnitus-related questionnaire has a comprehensive understanding of tinnitus from three aspects(functional scale, emotional scale and catastrophic scale).

  5. THI (Tinnitus Handicap Inventory) [The test is conducted 12 months after CI activation.]

    The tinnitus-related questionnaire has a comprehensive understanding of tinnitus from three aspects(functional scale, emotional scale and catastrophic scale).

  6. SSQ12 (Speech, Spatial and Qualities of Hearing Scale) [The test is conducted before the cochlear implantation.]

    SSQ12 questionnaire investigate the listening situation in daily environment, which is divided into three dimensions: speech perception, spatial hearing and auditory quality.

  7. SSQ12 (Speech, Spatial and Qualities of Hearing Scale) [The test is conducted 1 months after CI activation.]

    SSQ12 questionnaire investigate the listening situation in daily environment, which is divided into three dimensions: speech perception, spatial hearing and auditory quality.

  8. SSQ12 (Speech, Spatial and Qualities of Hearing Scale) [The test is conducted 3 months after CI activation.]

    SSQ12 questionnaire investigate the listening situation in daily environment, which is divided into three dimensions: speech perception, spatial hearing and auditory quality.

  9. SSQ12 (Speech, Spatial and Qualities of Hearing Scale) [The test is conducted 6 months after CI activation.]

    SSQ12 questionnaire investigate the listening situation in daily environment, which is divided into three dimensions: speech perception, spatial hearing and auditory quality.

  10. SSQ12 (Speech, Spatial and Qualities of Hearing Scale) [The test is conducted 12 months after CI activation.]

    SSQ12 questionnaire investigate the listening situation in daily environment, which is divided into three dimensions: speech perception, spatial hearing and auditory quality.

  11. QLBHE (Quality of Life for Bilateral Hearing Effect) [The test is conducted before the cochlear implantation.]

    QLBHE questionnaire is to evaluate the effect of bilateral listening in daily life after the use of assisted hearing devices.

  12. QLBHE (Quality of Life for Bilateral Hearing Effect) [The test is conducted 1 months after CI activation.]

    QLBHE questionnaire is to evaluate the effect of bilateral listening in daily life after the use of assisted hearing devices.

  13. QLBHE (Quality of Life for Bilateral Hearing Effect) [The test is conducted 3 months after CI activation.]

    QLBHE questionnaire is to evaluate the effect of bilateral listening in daily life after the use of assisted hearing devices.

  14. QLBHE (Quality of Life for Bilateral Hearing Effect) [The test is conducted 6 months after CI activation.]

    QLBHE questionnaire is to evaluate the effect of bilateral listening in daily life after the use of assisted hearing devices.

  15. QLBHE (Quality of Life for Bilateral Hearing Effect) [The test is conducted 12 months after CI activation.]

    QLBHE questionnaire is to evaluate the effect of bilateral listening in daily life after the use of assisted hearing devices.

  16. NCIQ (Nijmegen Cochlear Implant Questionnaire) [The test is conducted before the cochlear implantation.]

    The questionnaire evaluates the quality of life of patients from three dimensions: physiological function, psychological function and social function.

  17. NCIQ (Nijmegen Cochlear Implant Questionnaire) [The test is conducted 1 months after CI activation.]

    The questionnaire evaluates the quality of life of patients from three dimensions: physiological function, psychological function and social function.

  18. NCIQ (Nijmegen Cochlear Implant Questionnaire) [The test is conducted 3 months after CI activation.]

    The questionnaire evaluates the quality of life of patients from three dimensions: physiological function, psychological function and social function.

  19. NCIQ (Nijmegen Cochlear Implant Questionnaire) [The test is conducted 6 months after CI activation.]

    The questionnaire evaluates the quality of life of patients from three dimensions: physiological function, psychological function and social function.

  20. NCIQ (Nijmegen Cochlear Implant Questionnaire) [The test is conducted 12 months after CI activation.]

    The questionnaire evaluates the quality of life of patients from three dimensions: physiological function, psychological function and social function.

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age: 12 years old and above

  2. Language ability: postlingual deafness, able to cooperate with sentence test in noise

  3. Normal mental, intelligence and motor development

  4. Patients who meet the diagnosis of single-sided deafness and asymmetric hearing loss

Exclusion Criteria:
  1. Cochlear malformation (except large vestibular aqueduct syndrome)

  2. Retrocochlear lesions

  3. Incomplete implantation of cochlear implant electrodes

  4. Non-Chinese Mandarin communication

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Chinese PLA General Hospital

Investigators

  • Study Director: Shiming Yang, MD, Chinese PLA General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
YangShiming, College of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital, Chinese PLA General Hospital
ClinicalTrials.gov Identifier:
NCT05435612
Other Study ID Numbers:
  • SSD-2022-01
First Posted:
Jun 28, 2022
Last Update Posted:
Jun 28, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 28, 2022